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The transcriptional regulator GlnR of Streptococcus pneumoniae is involved in the regulation of glutamine
and glutamate metabolism, controlling the expression of the glnRA and glnPQ-zwf operons, as well as the gdhA
gene. To assess the contribution of the GlnR regulon to virulence, D39 wild-type and mutant strains lacking
genes of this regulon were tested in an in vitro adherence assay and murine infection models. All of the
mutants, except the glnR mutant, were attenuated in adherence to human pharyngeal epithelial Detroit 562
cells, suggesting a contribution of these genes to adherence during the colonization of humans. During murine
colonization, only the glnA mutant and the glnP-glnA double mutant (glnAP) were attenuated, in contrast to
glnP, indicating that the effect is caused by the lack of GlnA expression. In our pneumonia model, only glnP
and glnAP showed a significantly reduced number of bacteria in the lungs and blood, indicating that GlnP is
required for survival in the lungs and possibly for dissemination to the blood. In intravenously infected mice,
glnP and glnA were individually dispensable for survival in the blood whereas the glnAPmutant was avirulent.
Finally, transcriptome analysis of the glnAP mutant showed that many genes involved in amino acid
metabolism were upregulated. This signifies the importance of glutamine/glutamate uptake and synthesis for
full bacterial fitness and virulence. In conclusion, several genes of the GlnR regulon are required at different
sites during pathogenesis, with glnA contributing to colonization and survival in the blood and glnP important
for survival in the lungs and, possibly, efficient transition from the lungs to the blood.
Streptococcus pneumoniae is often carried asymptomatically
in the human nasopharynx. However, this gram-positive bac-
terium can cause disease upon dissemination to other sites of
the body, such as otitis media, pneumonia, septicemia, and
meningitis (3). To survive at various sites in the host, S. pneu-
moniae needs to metabolize available nutrients. In line with
this, several systems involved in nutrition and metabolism have
been suggested to be important for virulence. For example,
PsaA is part of an Mn(II) uptake system and contributes to
colonization and invasive disease (2, 13) while the Ami-AliA/
AliB oligopeptide uptake system contributes to colonization
only (15).
Nitrogen metabolism is of utmost importance for bacterial
survival and is therefore strictly regulated. Glutamine and glu-
tamate serve as main sources of nitrogen in the cell. We have
recently shown that in the pneumococcus, expression of genes
involved in glutamine metabolism is regulated by the transcrip-
tional regulator GlnR, which has a similar function in Bacillus
subtilis and Lactococcus lactis (5, 17, 19) (Fig. 1). In the pneu-
mococcus, the GlnR regulon consists of two operons, glnRA
and glnPQ-zwf, and the gdhA gene. The gene glnA encodes
glutamine synthetase GlnA, which forms glutamine out of glu-
tamate and ammonium while hydrolyzing ATP. The glnPQ
genes encode the main glutamine/glutamate transporter, and
zwf encodes glucose-6-phosphate 1-dehydrogenase, an enzyme
involved in pentose metabolism (17). The gene gdhA encodes
glutamate dehydrogenase, which converts 2-oxoglutarate and
ammonium to glutamate, thereby hydrolyzing NAD(P)H. We
have demonstrated that GlnR binds to a conserved operator
sequence present in the promoter regions of its target genes
(17). Regulation by GlnR is dependent on GlnA, as the GlnR
targets are derepressed in a glnA mutant and GlnA stimulates
binding of GlnR to its operator sequence (17). In addition,
GlnR regulation is responsive to glutamine and ammonium
(17, 19).
Importantly, expression of gdhA has been shown to be under
the control of a second regulatory protein, CodY (9, 17). This
transcriptional repressor has been studied extensively in B.
subtilis and L. lactis (6, 23, 28, 30) and recently in pneumococ-
cus (9). Targets of CodY have been shown to consist mainly of
genes involved in amino acid biosynthesis and uptake. It can be
expected that GdhA plays an important role in central amino
acid metabolism, as the expression of its gene is tightly regu-
lated by GlnR and CodY. In B. subtilis, a GlnR ortholog is
present, TnrA, which regulates various genes, including genes
involved in nitrogen metabolism (30, 33). TnrA activates sev-
eral genes during low nitrogen availability, and its DNA rec-
ognition site is similar to that of GlnR (5, 30, 33). In the
pneumococcus, no TnrA homologue is present, indicating dif-
ferences in the regulation of nitrogen metabolism from B.
subtilis.
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Signature-tagged mutagenesis screens have suggested that
several pneumococcal genes involved in glutamine metabolism
are required for full virulence (8, 20, 27). In group B strepto-
cocci, a mutant deficient in glnQ, the gene encoding a gluta-
mate transporter, is less able to adhere to and invade A549
respiratory epithelial cells in vitro. Furthermore, this mutant
showed a decreased virulence in a rat model of infection (29).
In Mycobacterium tuberculosis, glutamine synthetase GlnA1 is
essential for growth in macrophages (31). In another intracel-
lular pathogen, Salmonella enterica serovar Typhimurium, glnA
is regulated by the Ntr system (18). This gene shares an operon
with genes encoding the two-component system NtrB/C. Mu-
tation of glnA, ntrB, or ntrC resulted in a marked reduction of
virulence and a reduced ability to survive within host cells (18).
In this study, we assessed the importance of glutamine and
glutamate metabolism in S. pneumoniae by evaluating the con-
tribution of the glutamine/glutamate regulator GlnR and its
target genes, glnP, glnA, and gdhA, to pneumococcal virulence.
To this end, we investigated the ability of mutants with changes
in these genes to adhere to a human pharyngeal cell line in
vitro. Furthermore, we tested the individual contributions of
these genes in three murine infection models, representing the
three major phases of pneumococcal disease: colonization,
pneumonia, and bacteremia. In addition, we used microarray
analysis to examine the global gene expression of the glnA-glnP
mutant, which was severely affected in virulence.
MATERIALS AND METHODS
Bacterial strains and media. All of the strains used in this study were con-
structed in an S. pneumoniae D39 genetic background (NCTC 7466, serotype 2)
and are listed in Table 1. The glnAP mutant was constructed by transformation
of chromosomal DNA from the glnP deletion mutant to the glnA mutant and
selecting for erythromycin resistance (0.25 g/ml) on GM17 agar plates supple-
mented with 1% sheep blood (Johnny Rottier, Kloosterzande, The Netherlands).
Bacteria were checked for spectinomycin (150 g/ml) resistance and for the glnA
mutation by PCR. Stocks were frozen in 10% glycerol and stored at 80°C until
further use.
In vitro adherence. Adherence of pneumococci to epithelial cells was studied
essentially as described previously (4, 17). In short, the human pharyngeal cell
line Detroit 562 (ATCC CCL-138) was cultured in RPMI 1640 medium without
phenol red (Invitrogen) supplemented with 1 mM sodium pyruvate and 10%
fetal calf serum (FCS). Aliquots of bacteria (grown to mid-log phase in GM17
broth) stored at 80°C were thawed rapidly, harvested by centrifugation, and
resuspended in RPMI 1640 medium without phenol red supplemented with 1%
FCS to 1  107 CFU/ml. Monolayers of Detroit 562 cells in 24-well tissue culture
plates were washed twice with 1 ml phosphate-buffered saline (PBS), and 1 ml of
bacterial suspension was allowed to adhere for 2 h at 37°C in a 5% CO2
atmosphere. Nonadherent bacteria were removed by three washes with 1 ml
PBS, after which the Detroit 562 cells were detached by adding 200 l of
trypsin-EDTA and lysed by the addition of 800 l of ice-cold 0.025% Triton
X-100 in PBS. Serial 10-fold dilutions were plated on blood agar plates to count
the adherent bacteria and corrected to account for small differences in the count
in the initial inoculum. All experiments were performed in triplicate and re-
peated at least three times. Significant differences between the wild-type and
mutant strains were determined with the Mann-Whitney U test (P  0.05). The
wild-type and mutant strains grew comparably in RPMI medium (without phenol
red supplemented with 1% FCS) alone, without the addition of extra glutamine.
Experimental virulence in mice. Infection models were essentially performed
as described previously (9, 10, 15). Nine-week-old female outbred CD-1 mice
(Harlan, Horst, Netherlands) were used for all infection models. Prior to the
infection experiments, D39 wild-type and mutant strains were passaged in mice
as described previously (15). Cultures of mouse-passaged S. pneumoniae strains
were grown to an optical density at 600 nm of 0.3 and stored in aliquots at 80°C
in 10% glycerol. Prior to infection, these aliquots were spun down and the
bacteria were resuspended in sterile PBS to 106 CFU in volumes, depending on
the infection model used. Upon intranasal infection, mice were anesthetized with
2.5% (vol/vol) isoflurane-O2. At predetermined time points after infection, de-
pending on the infection model used, groups of mice were sacrificed by cervical
dislocation and samples were taken from various sites to determine the bacterial
load. During infection, signs of disease were closely monitored. If animals
FIG. 1. The pneumococcal GlnR regulon. GlnR regulates the expression of the glnRA and glnPQ-zwf operons and the gdhA gene. Repression
of gene expression by GlnR is responsive to high concentrations glutamine, glutamate, and ammonium. Moreover, regulation by GlnR requires
cellular GlnA for full repression of target genes.
TABLE 1. Bacterial strains used in this study
Strain Mutation(s) Function D39/TIGR4 accession no. Resistance cassette(s) Reference
cps cps Type 2 capsule locus SPD_0315-SPD_0328 Kanamycin 26
glnR glnR Glutamine synthetase repressor SPD_0447/SP_0501 Nonea 17
glnA glnA Glutamine synthetase SPD_0448/SP_0502 Spectinomycin 17
glnRA glnR, glnA Spectinomycin 17
glnP glnP Glutamine/glutamate transporter SPD_1098/SP_1241 Erythromycin 17
glnAP glnA, glnP Spectinomycin, erythromycin This study
gdhA gdhA Glutamate dehydrogenase SPD_1158/SP_1306 Erythromycin 17
a Premature stop codon introduced.
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reached a moribund state, they were sacrificed by cervical dislocation and ex-
cluded from the experiment prematurely. All animal experiments were per-
formed with approval from the Animal Experimentation Committee (DEC) of
Erasmus Medical Centre, Rotterdam, The Netherlands.
Colonization model of infection. In the colonization model, 10 l of PBS
containing 106 CFU of D39 wild-type or mutant bacteria was administered to the
nostrils of groups of five mice as described previously (14). Due to this small
volume, only the nose (nasopharynx) of the mouse becomes infected. Bacteria
were recovered from the nasopharynx by flushing the nose with 2 ml sterile PBS
(16), and lungs were removed from the body and homogenized in 2 ml of sterile
PBS with a hand-held homogenizer (polytron PT 1200; Kinematica AG). Viable
bacteria from the nasal lavage fluid, homogenized lungs, and blood samples were
quantified by plating serial 10-fold dilutions on Columbia blood agar (Oxoid)
supplemented with 5% (vol/vol) defibrinated sheep blood (Biotrading). Time
points for sampling were 30 min, 24 h, 48 h, 96 h, and 192 h postinfection. The
30-min time point is considered to be the start of the infection and is therefore
referred to as t  0. Bacteriology results are expressed as the geometric mean 
the standard error of the mean. Comparison of bacterial loads in the time course
experiment was performed with Student’s t test with P  0.05 considered statis-
tically significant.
Pneumonia model of infection. In the pneumonia model, five mice per group
were infected with 50 l of PBS containing 106 CFU of pneumococci. Bacteria
were recovered from the different sites as described above, with the addition of
a blood sample obtained by cardiac puncture. Viable bacteria isolated from the
nasal wash, homogenized lungs, and blood were quantified as described above.
Time points for sampling were 0, 12, 24, and 36 h postinfection. Bacteriology
results are expressed as the geometric mean  the standard error of the mean.
Comparison of bacterial loads in the time course experiment was performed with
Student’s t test with P  0.05 considered statistically significant.
Bacteremia model of infection. In the bacteremia model, groups of six mice
were infected by a tail vein with 106 CFU resuspended in 100 l of sterile PBS.
Bacteria were recovered from the blood by puncture of a lateral tail vein of the
same mouse at three predetermined time points after infection (0, 12, and 24 h)
and by cardiac puncture at the last time point, 36 h. In addition, mouse survival
times were scored. Two separate experiments were carried out, the first being
three groups of mice infected with the D39 wild-type, glnA, and glnR strains
and the second being four groups of mice infected with, again, D39 wild-type,
glnP, glnAP, and gdhA bacteria. Data from the two experiments were com-
bined, after which analysis of survival times was performed with the log-rank test
with P  0.05 considered statistically significant.
DNA microarray analysis. Microarray analysis was performed as described
previously (9, 10). In short, cultures of D39 wild-type and glnAP bacteria were
grown in GM17 in static flask cultures at 37°C. Cells were harvested when they
reached an optical density at 600 nm of 0.3 (mid-exponential growth phase).
Total RNA was isolated from both cultures as described previously and used to
generate fluorescent DNA probes by indirect labeling by standard methods (9,
10). After overnight hybridization, dual-channel array images were acquired with
a GeneTac LS IV confocal laser scanner (Genomics Solutions Inc.) and analyzed
with ArrayPro 4.5 software (Media Cybernetics Inc.). Spots were screened visu-
ally to identify those of low quality. Slide data were processed with MicroPreP as
previously described (9, 10, 32). Prior to analysis, automatically and manually
flagged spots and spots with very low background subtracted signal intensity (5%
of the weakest spots [sum of Cy3 and Cy5 net signals]) were filtered out of all
data sets. Net signal intensities were calculated by grid-based background sub-
traction. A grid-based Lowess transformation was performed for slide normal-
ization, negative and empty values were removed, and outliers were removed by
the deviation test. Further analysis was performed with a Cyber-T Student t test
for paired data (22). For identification of differentially expressed genes, only
genes with a minimum of six reliable measurements, a Bayesian P value of
0.001, a false-discovery rate of 0.05, and a standard deviation  ratio were
included. Since these criteria are purely statistical measurements of differential
gene expression and reproducibility across replicates, an additional change cutoff
of twofold was applied.
Microarray data accession number. The microarray data have been deposited
in the NCBI Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm
.nih.gov/geo/) under GEO Series accession number GSE9850.
RESULTS
Contribution of the GlnR regulon to in vitro adherence. To
assess the contribution of glutamine and glutamate metabolism
to pneumococcal virulence, directed mutants with changes in
glnR and genes regulated by GlnR were created. Deletions had
no effect on in vitro growth, except for the glnA mutant and the
glnA-glnP double mutant. These strains displayed slower
growth in GM17 broth, but upon addition of 0.5 mg/ml glu-
tamine, normal growth was restored. Similar observations were
made during growth in THY broth (data not shown).
Pneumococcal colonization is mediated by adherence to re-
spiratory epithelial cells. To assess the relevance of genes of
the GlnR regulon in the process of adhesion, we performed in
vitro adherence assays with the individual mutant strains. Since
unencapsulated strains tend to display significantly higher lev-
els of adherence than encapsulated strains (4), all mutants
were constructed in a capsule-negative isogenic derivative of
D39 (D39cps) (26). The adherence capacity of the glnA,
glnR, glnRA, and glnP mutant strains has been described
previously (17) and is included in this study for completeness
of analysis. All of the strains, except glnR, showed a severe
reduction in adherence of over 50% (P 0.05, Fig. 2A and B).
For the glnA mutant and the glnR-glnA double mutant, adher-
ence was approximately 44% of that of the wild type. This
effect was most likely caused by the glnA mutation, as the glnR
mutant adhered at wild-type levels. The number of adherent
glnP and glnA-glnP double-mutant bacteria was approximately
25% of that of the adherent wild-type bacteria. In this case, this
appeared to be mainly the result of the lack of glnP, as the glnA
mutant adhered at significantly higher levels, i.e., 44% of wild-
FIG. 2. In vitro adherence of pneumococcal mutants to the human
pharyngeal epithelial cell line Detroit 562. All strains were constructed
in a D39cps genetic background. The adherence of the mutants is
given as a percentage of that of the wild type (wt). *, P  0.05.
1232 HENDRIKSEN ET AL. INFECT. IMMUN.
 o
n
 July 13, 2012 by Universiteitsbibliotheek
http://iai.asm
.org/
D
ow
nloaded from
 
type adherence. Finally, deletion of zwf and gdhA also impaired
adherence to Detroit cells (27% and 20% of the wild-type
level, respectively).
Contribution of the GlnR regulon to colonization. In the
colonization model, extended colonization of the nasopharynx
without development of invasive disease is achieved by a small-
volume inoculum. Indeed, wild-type pneumococci were able to
colonize the murine nasopharynx for a period of 192 h (Fig. 3).
The level of colonization was fairly consistent for 48 h, i.e., 104
CFU/ml, after which the colonization level slowly started to
decrease to 103 CFU/ml at 192 h.
The colonization kinetics of the glnR mutant did not differ
significantly from those of the wild type during 192 h of colo-
nization (Fig. 3A). In contrast, the glnA mutant displayed a
clear attenuated phenotype. After 48 h throughout 96 h of
infection, mice infected with the glnA mutant had significantly
lower bacterial loads in the nasopharynx (Fig. 3A). At 192 h,
the difference was still present but it was not statistically sig-
nificant.
Neither the glnP mutant nor the gdhA mutant was signifi-
cantly attenuated during 192 h of colonization, whereas the
glnA-glnP double mutant was significantly attenuated after 24 h
of colonization and severely attenuated from 48 h onward, to
the point of being cleared at 192 h. Due to the relatively low
level of colonization by the wild type at 96 h, no significant
difference was reached at this time point (Fig. 3B). The more
severe attenuation of the glnA-glnP double mutant in compar-
ison to that of the glnA mutant is suggestive of an additive
effect of the glnP mutation to the colonization phenotype of
the glnA mutant.
Contribution of the GlnR regulon to pneumonia. In the
pneumonia model, the infection is monitored at three distinct
sites, i.e., the nasopharynx, the lungs, and the blood compart-
ment. This model allows assessment of the two ends of the
spectrum of pneumococcal infection, i.e., the progression from
nasopharyngeal colonization to invasive disease.
In agreement with the colonization model, we observed that
in the pneumonia model, mice infected with the glnA mutant
or the glnA-glnP double mutant had lower numbers of bacteria
in the nasal lavage fluid at 36 postinfection than wild-type-
infected mice, while bacterial loads in mice infected with the
glnR, glnP, or gdhA mutant did not differ from those in
wild-type-infected mice (data not shown).
During the 36-h infection period, we observed no significant
differences between bacterial loads in the lungs of mice in-
fected with the glnR mutant and those infected with wild-type
bacteria (Fig. 4A). Moreover, the glnR mutant was equally able
to enter the blood component after 12 h and onward (Fig. 4B).
Similarly, we did not observe significant differences between
the glnA mutant and the wild type, although the bacterial loads
in the lungs and blood tended to be higher than for the glnR
mutant at later time points. However, this difference did not
reach statistical significance (Fig. 4A). The glnP mutant was
attenuated after 36 h of infection in the lungs, indicating that
GlnP is required for full virulence in this model (Fig. 4C). In
addition, in glnP-infected mice fewer bacteria reached the
systemic circulation, suggesting that GlnP plays a role in the
dissemination of S. pneumoniae from the lungs to the blood-
stream (Fig. 4D). Bacterial counts of the glnA-glnP double
mutant decreased in time and were significantly lower from
12 h postinfection onward compared to wild-type counts (Fig.
4C). Moreover, no bacteria reached the bloodstream in mice
infected with the glnA-glnP double mutant (Fig. 4D), again
indicating a role for GlnP in the transition from the lungs to
the blood, with an additive effect of GlnA. The gdhA mutant
showed no difference in bacterial loads compared to the wild
type in either the lungs or the systemic circulation (Fig. 4C and
D), indicating that this gene is not required for full virulence in
this model.
Contribution of the GlnR regulon to bacteremia. In the
bacteremia model, infection of the bloodstream is followed for
36 h, allowing tracking of bacterial survival and growth within
individual mice. Moreover, comparison of results obtained
with the blood compartment in the pneumonia model enabled
us to discriminate between attenuation in bacterial survival in
blood or in the capability to disseminate from the lungs to the
blood component. As a measurement of disease potential, the
mean survival times of mice infected with the different strains
were compared.
Mice infected with D39 wild-type bacteria had a calculated
median survival time of 24 h, whereas glnR and glnA mu-
tant-infected mice had calculated median survival times of
28.25 and 34.25 h, respectively (Fig. 5). These differences in
median survival times were not statistically significantly differ-
ent from that of wild-type-infected mice. In addition, survival
times of mice infected with glnP (i.e., 30 h) and gdhA (i.e.,
24 h) were not significantly different from those of mice in-
fected with the wild type. However, all of the mice infected
FIG. 3. Colonization model. Shown are the bacterial loads in the
nasal lavage fluid of mice infected with D39 wild-type (wt), glnA, or
glnR bacteria (A) and D39 wild-type, glnP, glnAP, and gdhA
(B) bacteria. *, P  0.05.
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with the glnA-glnP double mutant survived until the end of the
experiment (36 h), indicating reduced virulence of the double
mutant during bacteremia (Fig. 5). Furthermore, all bacteria
were cleared from the bloodstream after 24 h (data not
shown).
Expression profile of the glnA-glnP double mutant. To in-
vestigate the effect of the concurrent deletion of glnA and glnP
on global gene expression, we performed microarray analysis
of D39 wild-type and glnAP bacteria.
Twelve genes were downregulated in the glnAP double mu-
tant. In addition to GlnR-regulated glnA, glnP, and glnQ, these
included genes encoding transcriptional regulators (e.g.,
SPD_0096, SPD_1524), ABC transporters (e.g., SPD_1526,
SPD_1607), the starving-cell-induced protein Dpr, and the
serine protease HtrA (Table 2).
Approximately 80 genes were upregulated in the glnA-glnP
double mutant, most of them involved in amino acid metabo-
lism (Table 2). Strikingly, many of these genes belong to the
CodY regulon, such as the Ami operon, the Ilv operon, and the
Liv operon (9). Also, gdhA, regulated by both GlnR and CodY,
was strongly upregulated. Interestingly, two putative transcrip-
tional regulators (SPD_0144 and SPD_0361) were upregu-
lated, which suggests that other regulatory systems are active to
complement the glnA and glnP mutations.
Of note, besides the genes within the GlnR regulon, no
overlap in differentially expressed genes of the glnA mutant
(described in reference 17) and the glnAP double mutant was
observed.
DISCUSSION
The ability to adequately adapt to changes in the availability
of nutrients is a prerequisite for bacterial survival. Several
studies have suggested that nitrogen metabolism, and espe-
cially glutamine metabolism, is important for the virulence of
pathogens (18, 29, 31). The transcriptional repressor GlnR
regulates, together with glutamine synthetase GlnA, genes in-
volved in glutamine/glutamate uptake and conversion in S.
pneumoniae, L. lactis, and B. subtilis (7, 17, 19). DNA-binding
assays have demonstrated that GlnR repression is dependent
on GlnA, but the exact mechanism remains unknown (17). As
FIG. 4. Pneumonia model. Shown are the bacterial loads in the lungs and blood of mice infected with D39 wild-type (wt), glnA, glnR, glnP,
glnAP, or gdhA bacteria. A and C, homogenized lungs; B and D, blood. *, P  0.05.
FIG. 5. Bacteremia model. Survival of mice infected with D39 wild-
type (wt), glnA, glnR, glnP, glnAP, and gdhA bacteria. *, P 
0.05.
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TABLE 2. Differentially expressed genes in D39 glnAP
Gene identifiera
Gene name Annotation Ratiob
D39 TIGR4/R6
SPD_0051 SP_0044 purC Phosphoribosylaminoimidazole-succinocarboxamide synthase 1.1
SPD_0111 spr0103 Argininosuccinate lyase 1.1
SPD_0142 SP_0139 Hypothetical protein 1.3
SPD_0143 spr0139 UDP-glucose 6-dehydrogenase 1.9
SPD_0144 SP_0141 mutR Transcriptional regulator 2.0
SPD_0145 SP_0142 Hypothetical protein 3.8
SPD_0146 SP_0143 CAAX amino-terminal protease family protein 3.9
SPD_0147 SP_0144 CAAX amino-terminal protease family protein 4.0
SPD_0148 SP_0145 ABC transporter, substrate-binding protein 3.9
SPD_0149 SP_0146 Hypothetical protein 1.7
SPD_0161 SP_0159 Hypothetical protein 3.9
SPD_0283 SP_0310 PTS system, IIC component 1.5
SPD_0300 SP_0327 Hypothetical protein 1.5
SPD_0334 SP_0366 aliA Oligopeptide ABC transporter 2.1
SPD_0335 SP_0368 Cell wall surface anchor family protein 1.4
SPD_0361 SP_0395 Transcriptional regulator, putative 1.4
SPD_0364 spr0361 ABC-type polar amino acid transport system 3.5
SPD_0404 SP_0445 ilvB Acetolactate synthase, large subunit 3.2
SPD_0405 SP_0446 ilvN Acetolactate synthase, small subunit 3.4
SPD_0406 SP_0447 ilvC Ketol acid reductoisomerase 3.1
SPD_0407 SP_0448 Hypothetical protein 2.5
SPD_0408 SP_0449 Hypothetical protein 2.7
SPD_0409 SP_0450 ilvA Threonine dehydratase 2.7
SPD_0424 SP_0474 PTS system, cellobiose-specific IIC component 1.1
SPD_0541 spr0470 blpO Bacteriocin 2.4
SPD_0652 SP_0749 livJ Branched-chain amino acid ABC transporter 1.0
SPD_0653 SP_0750 livH Branched-chain amino acid ABC transporter 1.4
SPD_0654 SP_0751 livM Branched-chain amino acid ABC transporter, permease protein 1.7
SPD_0655 SP_0752 livG Branched-chain amino acid ABC transporter 1.7
SPD_0656 SP_0753 livF Branched-chain amino acid ABC transporter 1.7
SPD_0749 SP_0856 ilvE Branched-chain amino acid aminotransferase 1.8
SPD_0751 SP_0858 Hypothetical protein 1.8
SPD_0752 SP_0859 Hypothetical protein 1.6
SPD_0753 SP_0860 pcp Pyrrolidone-carboxylate peptidase 1.7
SPD_0778 spr0786 Hypothetical protein 2.4
SPD_0778 SP_0882 Hypothetical protein 2.3
SPD_0780 SP_0884 Hypothetical protein 2.0
SPD_0780 spr0788 Hypothetical protein 1.9
SPD_0781 SP_0885 Hypothetical protein 2.3
SPD_0844 SP_0955 celB Competence protein 1.1
SPD_0900 SP_1013 asd Aspartate-semialdehyde dehydrogenase 2.0
SPD_0901 SP_1014 dapA Dihydrodipicolinate synthase 2.1
SPD_1004 SP_1119 gapN Glyceraldehyde-3-phosphate dehydrogenase, NADP dependent 2.2
SPD_1011 SP_1126 glxK Glycerate kinase 1.1
SPD_1156 spr1179 Putative iron-dependent peroxidase 1.0
SPD_1158 SP_1306 gdhA NADP-specific glutamate dehydrogenase 2.1
SPD_1190 SP_1356 Atz/Trz family protein 1.1
SPD_1191 SP_1357 ABC transporter, ATP-binding/permease protein 1.1
SPD_1192 SP_1358 ABC transporter, ATP-binding/permease protein 1.3
SPD_1276 spr1302 Hypothetical protein 1.3
SPD_1464 SP_1651 psaD Thiol peroxidase 1.3
SPD_1472 SP_1659 ileS Isoleucyl-tRNA synthetase 1.1
SPD_1500 SP_1688 ABC transporter, permease protein 1.1
SPD_1563 spr1598 Dicarboxylate/amino acid:cation (Na or H) symporter 1.3
SPD_1564 SP_1754 Hypothetical protein 1.1
SPD_1585 spr1620 ABC transporter, sugar-binding protein 1.7
SPD_1596 SP_1811 trpA Tryptophan synthase, alpha subunit 1.1
SPD_1602 SP_1817 trpE Anthranilate synthase component I 1.1
SPD_1649 SP_1869 fatD Iron compound ABC transporter, permease protein 1.5
SPD_1650 SP_1870 fatC ABC transporter membrane-spanning permease, ferric iron transport 1.5
SPD_1651 SP_1871 fecA ABC transporter ATP-binding protein, ferric iron transport 1.1
SPD_1652 SP_1872 fatB Iron compound ABC transporter, iron compound-binding protein 1.1
SPD_1667 SP_1887 amiF ABC transporter, ATP-binding protein, oligopeptide transport 1.1
SPD_1668 SP_1888 amiE ABC transporter, ATP-binding protein, oligopeptide transport 1.3
SPD_1669 SP_1889 amiD ABC transporter, membrane-spanning permease, oligopeptide transport 1.2
SPD_1670 SP_1890 amiC ABC transporter membrane-spanning permease, oligopeptide transport 1.1
Continued on following page
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a result, GlnR targets are derepressed in a glnA mutant. In this
study, we investigated the contribution of the transcriptional
regulator GlnR and its target genes to pneumococcal viru-
lence, in particular, its contribution during colonization, pneu-
monia, and bacteremia in mice.
Absence of GlnR had no significant effect on bacterial vir-
ulence in any of the three infection models we used. It could
well be that levels of available glutamine in the nasopharynx
and in the lungs are quite low and, hence, no repression by
GlnR is triggered. Alternatively, all genes of the GlnR regulon
might be expressed in the glnR strain, and redundant expres-
sion of these genes might not influence the ability to colonize
or cause disease.
The conversion of glutamate to glutamine appears to be
required during colonization, as the mutant lacking GlnA was
found to be attenuated in colonization of the murine naso-
pharynx. Alternatively, the lack of GlnA might affect regula-
tion by GlnR through derepression of its gene targets, al-
though this appears less likely given the lack-of-colonization
phenotype of the glnR mutant. Attenuation of the glnA mutant
was not observed in the lungs and bloodstream in the pneu-
monia and bacteremia models of infection, indicating that
GlnA is not required for bacterial survival in the lungs and the
transition from the lungs to the blood in our infection models.
GlnP, which is part of the main glutamine/glutamate ABC
transporter GlnPQ, is not required for colonization of the
murine nasopharynx. Interestingly, GlnP was found to be in-
volved in adherence to Detroit 562 cells, suggesting a role in
colonization in humans. The possibility cannot be excluded
that the difference between in vitro adherence and the murine
colonization model reflects the differences between the in vitro
and in vivo settings. For instance, expression of glnP might be
required in RPMI medium, but not in the murine (or human)
nasopharynx. In group B streptococci, it has been proposed
that glnQ, also part of the glutamine/glutamate transporter, is
involved in adherence to fibronectin and virulence in rats,
possibly by modulating cytoplasmic glutamine levels (29). GlnP
was also identified as a candidate for fibronectin binding by
phage display library analysis (1). However, binding of fi-
bronectin by GlnP of streptococci has never been confirmed,
suggesting an indirect involvement (1, 29). In the pneumonia
model, mice infected with the glnP mutant showed a lower
bacterial load in the lungs at 36 h than wild-type-infected mice.
Strikingly, while the number of wild-type bacteria increased
with time, fewer glnP mutants reached the bloodstream from
24 h postinfection onward. This suggests a role for GlnP in the
transition from the lungs to the bloodstream. Uptake of glu-
tamine could be of importance at this stage of infection, i.e.,
entering the bloodstream. The impaired glutamine uptake in
the glnP mutant might therefore create a growth disadvantage,
leading to a smaller number of bacteria in the blood circula-
tion. However, we cannot rule out the possibility that the glnP
phenotype, i.e., impaired transition from lungs to blood, is
caused by multiple factors. Fewer bacteria cause less tissue
damage in the lungs, and this will consequently lead to less
spillover into the blood. One such example might be lower
pneumolysin concentrations due to lower bacterial loads in the
lungs (11).
The glnA-glnP double mutant displayed an attenuated phe-
notype similar to that of the glnA mutant in the colonization
model, most likely caused by the glnA mutation only, given the
lack-of-colonization phenotype of the glnP mutant. Moreover,
since GlnP is part of the main glutamine and glutamate trans-
porter (17), our data suggest that pneumococcus, while colo-
nizing the murine nasopharynx, is able to acquire glutamine
and glutamate through other processes such as peptide uptake
and degradation. Different results were obtained in the lungs;
here, the glnA mutation alone did not result in attenuation
TABLE 2—Continued
Gene identifiera
Gene name Annotation Ratiob
D39 TIGR4/R6
SPD_1783 SP_1986 Hypothetical protein 1.1
SPD_1840 SP_2031 Predicted Zn-dependent hydrolases of the 	-lactamase fold 1.3
SPD_1845 SP_2036 PTS system, ascorbate-specific IIA component, PTS-EII 1.3
SPD_1954 SP_2125 Hypothetical protein 2.2
SPD_1981 spr1961 Hypothetical protein 1.1
SPD_1985 SP_2157 adh2 Alcohol dehydrogenase, iron containing 1.0
SPD_1988 SP_2160 Hypothetical protein 1.1
SPD_1994 SP_2166 fucA L-Fuculose-phosphate aldolase 1.2
SPD_0096 SP_0100 Transcriptional regulator, PadR family protein 1.0
SPD_0381 SP_0418 acp Acyl carrier protein 1.0
SPD_0448 SP_0502 glnA glnA, glutamine synthetase 6.5
SPD_0803 SP_0910 Hypothetical protein 1.1
SPD_1098 SP_1241 glnP Glutamine/glutamate transporter 6.2
SPD_1099 SP_1242 glnQ Glutamine/glutamate transporter 3.2
SPD_1402 SP_1572 dpr Starved-cell-like peroxide resistance protein 1.1
SPD_1524 SP_1714 Transcriptional regulator, GntR family protein 1.3
SPD_1526 spr1560 Hypothetical protein (ABC-2 transporter) 1.1
SPD_1526 SP_1715 Hypothetical protein, ABC-2 type transporter 1.2
SPD_1607 SP_1824 ABC transporter, permease protein 
Fe(III) 1.2
SPD_2068 SP_2239 htrA Serine protease 1.1
a Gene identifier as deposited in the NCBI Gene Expression Omnibus (GEO) database under GEO Series accession number GSE9850 (TIGR4, SP; R6, SPR). Genes
directly regulated by GlnR are in boldface.
b The microarray ratio is a log2-transformed expression of glnPA expression with respect to that of the wild-type strain.
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whereas mutation of both glnA and glnP did, suggesting that
pneumococcus cannot easily use other sources for acquisition
of glutamine at this particular site. The double mutant is not
able to convert glutamate to glutamine (GlnA) and is not able
to take up free glutamate or glutamine (GlnP). Consequently,
the double mutant has to rely on another system for acquiring
these amino acids. If this is so, such a system is apparently not
able to complement the lack of GlnA and GlnP sufficiently
when pneumococci reach the lungs or blood circulation, in
contrast to the nasopharynx, where only glutamine synthesis
(GlnA) contributes to survival. The glnAP mutant was able to
grow in defibrinated blood in vitro, but this growth was slower
and to a lower cell density than that of the wild type. Addition
of glutamine rescued the phenotype of glnAP to wild-type
growth (data not shown). This suggests that, when added in
high concentrations, glutamine can enter the cell, possibly by
other uptake systems with very low affinity for glutamine or by
passive diffusion.
The microarray data showed that predominantly genes in-
volved in amino acid metabolism are upregulated in the glnAP
mutant. These genes, most of them belonging to the CodY
regulon (9), are probably upregulated because the double mu-
tant is starved for amino acids, glutamine in particular. Al-
though glutamine was present in the medium used for the
expression study, the gene-regulatory network sensing and
controlling general amino acid metabolism seemed perturbed.
This is underscored by the differential expression of four tran-
scriptional regulators; however, their function is unknown.
This suggests that regulation of amino acid metabolism within
the pneumococcal cell is quite complex and has severe effects
on fitness and virulence. The impact on virulence could also be
explained by the twofold downregulation of the expression of
htrA in the glnAP mutant, as it was shown previously that this
gene is required for virulence in D39 (12).
The gene gdhA, encoding glutamate dehydrogenase, does
not appear to be required for virulence at any site in our
infection models. No paralog of gdhA is present in the pneu-
mococcal genome, which could complement its metabolic
function. Regulation of gdhA by CodY has been described and
might be the principal regulator in vivo by repressing gdhA
expression (9, 17). Possibly, gdhA expression is coordinated in
such a way that it is only activated under specific conditions
(e.g., nitrogen limitation) and these conditions are not encoun-
tered by the pneumococcus in our mouse models.
We have described the behavior of mutants lacking genes of
the GlnR regulon, the regulatory system of glutamine and
glutamate metabolism, during adherence to human pharyngeal
epithelial cells in vitro and experimental virulence in mice. We
have identified two genes that play a role in virulence, namely,
glnA and glnP. glnA encodes glutamine synthetase, which is
required for colonization, and glnP encodes a membrane glu-
tamine/glutamate permease which is required for survival in
the lungs and possibly for the transition from the lungs to the
blood circulation. This study provides novel insight into the
nutritional requirements of S. pneumoniae within its host,
more specifically, the glutamine and glutamate requirements.
The different phenotypes of mutants during in vitro adherence
to human pharyngeal cells and colonization of the murine
nasopharynx suggest that different host species (i.e., mice and
humans) may have different adhesion properties and nutri-
tional supplies for the bacterium.
Many studies have shown that expression of pneumococcal
proteins during pathogenesis is required at different stages of
infection (15, 21, 25). One study, performed by Oggioni and
coworkers, presents evidence that the “transcriptional state” of
the pneumococcal cells differs at particular niches within the
host (24). The bacterium has to deal with the supply of nutri-
ents that each site of the body offers. For this reason, coregu-
lation of site-specific metabolic and virulence factors by nutri-
tional regulators is likely to occur. In this study, we report on
the role of glutamine/glutamate metabolism and its regulation
in our experimental models of virulence in mice. The site-
specific requirements for GlnA and especially GlnP reported
in this study might offer novel strategies to explore these mol-
ecules as future drug targets that specifically target invasive
disease while leaving colonization unaffected.
In conclusion, genes within the GlnR regulon are of definite
importance for bacterial survival within our experimental mod-
els of infection, with different subsets of the genes involved in
glutamine/glutamate metabolism contributing to pneumococ-
cal survival during different stages of infection.
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